Health Highlights: May 1, 2023
Suicide rates among U.S. adolescents doubled in 10 years. Suicide rates among 13- and 14-year-old Americans were on the rise between 2008 and 2018, and suicide is now the No. 1 cause of death in this age group, a new report finds. Read moreCould long …
Learn MoreStruggles With COVID Left Many Americans With Medical Debt
MONDAY, May 1, 2023 (HealthDay News) — While COVID-19’s toll on health and wellness has been obvious, the virus has also hit people in the wallet.A new study links surviving COVID to financial challenges later, especially for folks who were hospitali…
Learn MoreSimilar to Humans, Sleep Is Altered for Dogs With Dementia
MONDAY, May 1, 2023 (HealthDay News) — Like people, man’s best friend can get dementia with aging.And these older dogs sleep less deeply when they develop the condition, just as people with Alzheimer’s disease do, according to research that included …
Learn MoreChild Drowning Tragedies Can Be Prevented
SUNDAY, April 30, 2023 (HealthDay News) — Drowning isn’t always accompanied by the stereotypical flailing and cries for help.It can happen wherever there’s water, including streams, lakes, water parks, bathtubs and even toilets.It’s also often preven…
Learn MoreHow to Ease Back Into Exercise After Surgery
SATURDAY, April 29, 2023 (HealthDay News) — Patients who’ve had surgery should ease back into movement and exercise. These efforts may be small, but they’re better than nothing, according to one surgeon who emphasized the importance of listening to y…
Learn MoreIn California Study, Many Veterans at Risk of Suicide Have Unlocked Gun at Home
FRIDAY, April 28, 2023 (HealthDay News) — A new study on veterans, gun storage, and suicidal thoughts points to an urgent need for mental health and substance-related services, according to researchers.The study from the UCLA Center for Health Policy…
Learn MoreNew COVID-19 Drug Guards Against All Variants in Immunocompromised
FRIDAY, April 28, 2023 (HealthDay News) — A new antibody drug to help fight COVID-19 infection in immunocompromised people may be available by the end of the year.AstraZeneca said Thursday that its treatment, called AZD3152, appears to work in all va…
Learn More